Hikma epinephrine nasal spray submissions accepted in the United States
Hikma Pharmaceuticals says regulators in the United States have accepted for review its regulatory submissions for its epinephrine nasal spray. The spray is being developed for emergency treatment of allergic reactions (anaphylaxis).